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The variegated picture oftuiberculous infection, both spontaneous
in man and experimentally induced in animals, has puzzled students
and led to most complicated explanations. Most of the earlier
experimental studies were handicapped by the lack of two funda-
mentals which now appear so essential to a solution. One of these
was the primary lack of information on the tubercle bacillus and its
virulence or avirulence, and the other was the necessity for an exact
interpretation of the quantitative relations between the bacilli and
the host as expressed in the evaluation of infection and specific
immunity. As long as tuberculin and tuberculin allergy were fitted
into the picture of specific immunity, and tuberculin allergy was
viewed as synonymous with immunity, progress was hampered
because of an experimental phenomenon which did not exist natu-
rally.' However, with a better conception of the avirulence of
tubercle bacilli, stressed by Calmette with BCG, and a full recogni-
tion of grades of virulence of mammalian bacilli, it became possible
to evaluate more exactly the elements involved in specific tubercu-
ltosis immunity, to understand its mechanism better, and to determine
its part in experimental infection and recovery. It had frequently
been noted that certain strains of tubercle bacilli would not infect
all of the experimental animals uniformly though used in relatively
large amounts, and yet those animals that were infected became defi-
nitely tuberculous. These observations were made frequently on
guinea-pigs infected with mammalian tu'bercle bacilli to which they
were usually acknowledged to be highly suscepti'ble. In earlier
studies it was shown that a relative specific tuberculosis immunity is
produced readily and consistently by viable avirulent mammalian
tubercle bacilli,6 and that this immunity must be produced actively
and cannot be transmitted from mother to offspring4 or passively
transferred by the injection ofblood or plasma. This specific tuber-
culosis immunity is quantitative and depends on a number of factors,
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including, more particularly, the time factor and the amount of
immunizing agent used for vaccination.3
During a survey of the virulence of tubercle bacilli harbored
by old cases of pulmonary tuberculosis,2'
5 a number of human
tubercle bacilli of moderate or low virulence were recovered from
the sputum. Graded amounts from I mg. to 0.000,001 mg. were
injected subcutaneously into guinea-pigs, and I mg. was also given
intravenously.
As was shown previously, the results of either intravenous or
suibcutaneous injections of highly virulent human tuberdle bacilli
into guinea-pigs are an early lethal effect with large amounts of
bacilli or definite tuberculosis with small amounts of bacilli (around
10-` mg.). Regardless of amount, up to 10 mg., avirulent human
or bovine tubercle bacilli injected intravenously or subcutaneously
TABLE 1
THE RESULTS OF INTRAVENOUS AND SUBCUTANEOUS INFEGTION TESTS IN
GUINEA-PIGS WITH HUMAN TUBERCLE BACILLI OF LOW VIRULENCE
Amount injected subcutameously and tuberculous
I mg. injected involvement after 3 months
Strain intravenously 1 mg. 0.001 mg. 0.000,001 mg.
0* 3 0
M. C. Died 44 days 0 2 0
Died 44 days 3 2 0
3 4 3
0 2 0
W. R. Died 46 days 4 3 0
Died 53 days 4 3 1
4 3 1
0 4 0
L. F. Died 50 days 4 3 0
Died 61 days 1 4 0
_ _ _ _ _ _ _ _ _ _ _ ~~~2 3 2
*The tuberculous involvement is graded from 0 = no organ tuberculosis to
4 = a massive generalized disease.
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in guinea-pigs, will not cause progressive tuberculosis. With human
tubercle bacilli of low virulence (so-called attenuated organisms)
the picture may beirregular in that the larger amounts injected, par-
ticularly if given subcutaneously, lead to results such as are recorded
in Table 1 and illustrated in Fig. 1.
The three strains, M. C., W. R., and L. F., were isolated from
the sputum of patients with pulmonary tuiberculosis of over ten
years' duration. While 1 mg. given intravenously proved lethal
within 44 to 61 days, the subcutaneous injection of the same amount
(1 mg.) did not always produce tuberculosis of the internal organs.
A smaller amount (0.001 mg.) usually resulted in the development
of organ tuberculosis in all guinea-pigs thus injected. Very small
amounts (0.000,001 mg.) given subcutaneously would infect only
occasional guinea-pigs. In view of the results recorded in Table 1,
we offer the explanation of the fact that large amounts of bacilli
used subcutaneously result inthe development of a sufficiently potent
specific immunity to retard further general infection from the local
site of inoculation. A quantitative relation between infecti'on and
immunity has been pointed out earlier.3 When smaller injections
of these bacilli of low virulence are used, the amount and extent
of specific immunity developed are unable to cope with the infection
before it becomes established generally. It appears to be a matter
of reaction between multiplying bacilli retarded by a graded type
of specific immunity, for which we have no measure at present
except the actual infection test.
In order to illustrate further the part of specific tuberculosis
immunity in infection in the guinea-pig, an experiment was planned
in which avirulent human tubercle bacilli were mixed with small
amounts of highly virulent human tuberde bacilli, the mixture being
given subcutaneously. In addition, in another experiment, the
avirulent human tubercle bacilli were injected subcutaneously one
week prior to a small injection of a small amount of virulent bacilli
in a different site. In the usual immunity experiment, an interval
of three weeks to a month or more passes between the vaccination
and the injection with virulent bacilli. The results of the foregoing
experiments are recorded in Table 2 and illustrated in Fig. 2.
The findings recorded in Table 2 indicate that 1 mg. of avirulent
human tubercle bacilli mixed with 0.000,1 mg. of highly virulent
human tubercle bacilli and injected subcutaneously in guinea-pigs
results in a definite retardation of the tulberculosis developed in these
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TABLE 2
THE EFFECT OF COINCIDENT AND PRIOR (1 WEEK) INJECTION OF AVIRULENT
HUMAN TUBERCLE BACILLI ON INFECTION BY RELATIVELY SMALL
AMOUNTS OF HIGHLY VIRULENT HUMAN TUBERCLE BACILLI (H 160)
Tuberculous involvement 3 months after subcutaneous injection of
I mg. 0.001 mg. I mg. 0.001 mg. 0.000,1 mg. 0l mg.
avirulent avirulent avirulent avirulent virulent virulent
bacilli bacilli bacilli bacilli bacilli bacilli
+ + I week I week Infection Infection
0.000,1 mg. 10 mg. prior to* prior to* control control
virulent virulent 0.000,1 mg. I 0- mg.
bacilli bacilli virulent virulent
bacilli bacilli
2t 0 1 0 4 1
1 I 0 0 4 2
0 0 1 0 3 3
0 1 0 0 4 2
*The avirulent bacilli were injected subcutaneously 1 week prior to the date
of injecting the controls and to the time of giving the injections of mixtures of
avirulent and virulent bacilli. This permitted the use of the same suspensions of
virulent bacilli throughout the experiment.
tThe extent of the tuberculosis found in the guinea-pigs was graded from
0=no organ tuberculosis to 4=generalized massive disease.
animals when compared with controls infected only with the same
amount and suspension of the highly virulent bacilli. When the
avirulent bacilli are used in the 0.001 mg. amount and the virulent
in the 0.000,001 mg. amount, a similar retardation in the tuber-
culosis occurs. When the same relativeamounts ofavirulent human
tubercle bacilli are given subcutaneously one week prior to the viru-
lent human tubercle bacilli (subcutaneously in a different site), a
mcre pronounced retardation of the tuberculosis is noted 3 months
after infection.
In view of the foregoing experiment and to note the effect of
the coincident injection of viable, of heat-killed, and of chemically
killed avirulent human tubercle bacilli upon the le6ions, both local
and general, resulting from the small virulent infection, five groups
of guinea-pigs were injected. Each of the guinea-pigs in experi-
ment 1 was given a single intracutaneous injection of 0.000,001 mg.TUBERCULOSIS IMMUNITY DURING INFECTION
of a virulent strain of human tubercle bacilli (H 160) as infection
contral; each pig in experiment 2 was given a single injection of
0.01 mg. of viable avirulent human tuberde bacilli intracutaneously
(avirulent reaction control); in experiment 3, the 0.000,001 mg.
of virulent human tubercle bacilli (H 160) was mixed with the
0.01 mg. of viable avirulent human tuberde bacilli and injected
intracutaneously; in experiment 4, the 0.000,001 mg. of virulent
human tubercle bacilli (H 160) was mixed with 0.01 mg. of heat-
killed (30 minutes in boiling water-bath) avirulent human tubercle
bacilli; and in experiment 5, the 0.000,001 mg. of virulent human
tubercle bacilli (H 160) was mixed with 0.01 mg. of chemically
killed avirulent human tuberde bacilli. The latter bacilli were
killed chemically in suspension by treating with 2.5 per cent acetic
acid at incubator temperature (370 C.) for four hours and neutraliz-
ing the suspension by means -of 4 per cent sodium hydroxide before
mixing with the viable virulent bacilli. The results of two such
series are summarized in Table 3 in which only the tuberculous
internal organ involvement is noted. The pertinent findings with
respect to the local intracutaneous sites of injection were as follows:
in the earlyweeks of theexperiment, the intracutaneous lesion result-
ing from the mixture of the viable virulent with the viable avirulent
human tubercle bacilli developed more rapidly and was larger than
that resulting from the viable avirulent bacilli injected alone or the
TABLE 3
THE EFFECT OF COINCIDENT INJECTION OF VIABLE AND NON-VIABLE (HEAT-KILLED
AND CHEMICALLY KILLED) TUBERCLE BACILLI ON INTRACUTANEOUS INFECTION
WITH SMALL AMOUNTS OF VIRULENT HUMAN TUBERCLE BACILLI (H 160)
1~~~ ~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Organ tuberculosis 64 days after the intracutaneous injection of
r .-..A
0.000,001 mg. 0.000,001 mg. 0.000,001 mg. 0.000,001 mg.
virulent virulent virulent virulent
bacilli bacilli bacilli bacilli
+ + +
0.01 mg. 0.01 mg. 0.01 mg. Infection
avirulent heat-killed chemically killed control
bacilli avirulent avirulent
bacilli bacilli
0* 2 3 1
*The tuberculosis involvement is graded from 0 = no organ tuberculosis to
4 = generalized massive disease.
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mixture of virulent bacilli with the non-viable bacilli (heat or chem-
ically killed), and the local lesion resulting from the virulent bacilli
alone, once it became visilble, developed much more rapidly because
of the ultimate multiplication of the virulent bacilli locally.
The results recorded in Table 3 show a definite retardation in
the general tuberculosis resulting from the coincident injection of
the viable avirulent human tubercle bacilli, while an equivalent
amount of heat-killed or chemically killed avirulent bacilli injected
intracutaneously with the virulent bacilli resulted in a definite
increase in the general ttXberculosis in the guinea-pigs 64 days after
injection when compared with the infected control guinea-pigs given
the virulent bacilli alone. It is evident from this experiment that
the viable avirulent human tubercle bacilli coincidently injected
intracutaneously into the guinea-pigs has caused a definite alteration
in the specific immune condition of these animals which leads to a
pronounced retardation of the general disease. Such influence was
not exerted by the heat or chemically killed bacilli. On the other
hand, it seems that these killed bacilli were able to favor the local
development of the virulent bacilli and the progress of the general
disease wasenhanced without thecoincdent stimulation of the specific
immune condition by the killed bacilli or the rapidly developing
virulent bacilli. This is illustrated by the pictures in Fig. 3 taken
of typical animals from these experiments.
Summary and Cotwlusions
1. When graded amounts (from I mg. to 0.000,001 mg.) of
human tubercle bacilli of low virulence are injected sizbcutaneously
into guinea-pigs, an asbsence of organ tuberculosis following the
injection of the larger amounts of viable bacilli (1 mg.) is noted
frequently, while organ tuberculosis is definitely produced in these
animals by the 0.001 mg. amount and occasionally even by the
0.000,001 mg. amount.
2. When appropriate amounts of viable avirulent human tubercle
bacilli are given subcutaneously coincident with or 1 week prior
to infection with virulent human tubercle bacilli, a definite retarda-
tion of the infection in guinea-pigs occurs.
3. When appropriate amounts of viable avirulent human tubercle
bacilli are injected intracutaneously with small infecting amounts
of virulent human tubercle bacilli, an enhanced local reaction occurs
at first, followed by a markedly diminished general organ tubercu-
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losis. Heat or chemically killed avirulent human tubercie bacilli
intracutaneously injected coincidently with virulent human tubercle
bacilli exert an apparent enhancing effect on the subsequent organ
tuberculosis developed in the animals from the virulent infection.
4. From these experiments, the phenomenon of retardation of the
organ tuberculosis in guinea-pigs infected with bacilli of low viru-
lence appears to be due to the effect of the coincident development
of a sufficient grade of relative specific immunity produced by the
initial injection of the large amount of viable bacilli to retard or
inhibit compJetely the otherwise slow development of these tubercle
bacilli in the animal. This phenomenon of specific immunity is the
counterbalance held against the bacillary development when these
bacilli enter intravitally into the body and it helps to account for
the prolonged chronicity of the disease in man.
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FIG. 1. The results of subcutaneous inlfection with human ttibercle bacilli of low virulenice
(L. F. strain):
a. Organs cf a guinea-pig 3 moniths after receiving 1 mg.
b. Organs of a guinea-pig 3 niiontlis after receiving 0.001 mg.
c. Organs of a guinea-pig 3 motnths after receiving 0.000,00- nig.
Note the absenlce of tuberculosis in a and c; its presence in b, which received the initermediate
dosage.
FIG. 2. The results of subcutaneous infection with virulent tubercle bacilli when avirulent
human tubercle bacilli are given simultaneously with and 1 week prior to injection of the virulent
organisms:
a. Organs of a guinea-pig 3 months after the simultaneous injection of 1 mg. of avirulent human
bacilli and 0.000.1 mg. of virulent bacilli.
b. Organs of a guinea-pig 3 months after the injection of 0.000,1 mg. of virulent bacilli, this
injection having been preceded by 1 week by an inijection of 1 nig. of avirulent bacilli.
c. Infection control. Organs of a guinea--pig which had received 0.000,1 mg. of virulent bacilli.
d. Organs of a guinea-pig which had received, 3 months before, simultaneous injections of 0.001 mg.
of avirulent bacilli and 0.000.001 mg. of virulent bacilli.
e. Organs of a guinea-pig 3 months after an injection of 0.000,001 mg. of vlruleuit bacilli given
1 week after an injection of 0.001 mg. of avirulent bacilli.
f. Infection control. Organs of a guinea-pig which, 3 months earlier, had received 0.000,001 mg.
of virulent organisms.
Note tile abseiice or the retardation of iiifectiotn iii those aninials wvhich hiail receixedthe avirulent
bacilli simultaneously with or 1 week before the injection of virulent bacilli.~~~~C ci
FIG. 3. The effect of simultaneous iniection of viable and of nonl-viable (heat-killed or chemii-
ically killed) avirulent human tubercle bacilli on intracutaneous infection niiduced hy small amotunits
of virulent human tulercle bacilli. Note the absence cr the extent of organ tuberculosis foulnd
in the guinea-oigs 64 (lays after the intracutaneotus inijection of:
a. 0.01 mg. of viable aviruleilt human tubercle bacilli mixed with 0.000,001 nmg. of virulent hunman
bacilli. Organ tuberculosis absent.
b. 0.01 mg. of heat-killed avirulent human tubercle bacilli mixed with 0.000,001 mg. of virulent
humanl bacilli. Organi tuberculosis nmore marked thani in d., the inlfection colntrol.
c. 0.01 nmg. of chemiiically killed (acetic acid) avirulenit humzanl tubercle bacilli nmixed with 0.000,001
mng. of virulenit human bacilli. Organi tuberculosis slightly greater than in b.
d. 0.000,001 mg. of virulent human tubercle bacilli. Infection control.